RSS-Feed abonnieren

DOI: 10.5935/1984-0063.20170020
Crude and Adjusted Prevalence of Sleep Complaints in Mexico City

ABSTRACT
OBJECTIVE: To estimate the crude prevalence rates of several sleep complaints and the prevalence for each one adjusted for the coexistence of symptoms in other sleep domains in a representative sample of adult individuals from Mexico City.
METHODS: A probabilistic sample of 1933 adult individuals living in Mexico City was surveyed using fourteen questions of the Sleep Disorders Questionnaire to assess sleep-related symptoms and sleep complaints. Estimates of crude prevalence rates for each sleep disturbance and adjusted for a score ≥ the 80th. percentile in the questionnaire were calculated.
RESULTS: The following prevalence rates were found: insomnia 39.7%; excessive diurnal sleepiness (EDS) 20.9%; obstructive sleep apnea syndrome (EDS plus snoring) 7.7%; habitual snoring 9.9%; restless legs syndrome (RLS) 4.4%; narcolepsy 0.9%; sleep paralysis (SP) 13.2%; and hypnotic use 1.2%. When prevalence rates were calculated accounting for symptoms in other sleep domains, notable reductions were observed in complaints of insomnia (17.3%), EDS (10.3%), and SP (8.7%), while minor decreases were observed for complaints of snoring (7.4%), OSAS (5%), and RLS (3.8%); narcolepsy prevalence practically did not change (0.9%).
CONCLUSIONS: Sleep complaints are highly prevalent in Mexican adult population. More than a half of the individuals with a given sleep disturbance have a global sleep deterioration associated to psychosocial and health impairments.
Publikationsverlauf
Eingereicht: 30. Juni 2016
Angenommen: 24. Februar 2017
Artikel online veröffentlicht:
11. Oktober 2023
© 2023. Brazilian Sleep Association. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)
Thieme Revinter Publicações Ltda.
Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil
-
REFERENCES
- 1 Ellen RL, Marshall SC, Palayew M, Molnar FJ, Wilson KG, Man-Son-Hing M. Systematic review of motor vehicle crash risk in persons with sleep apnea. J Clin Sleep Med. 2006;2(2):193-200.
- 2 Terán-Santos J, Jiménez-Gómez A, Cordero-Guevara J. The association between sleep apnea and the risk of traffic accidents. Cooperative Group Burgos-Santander. N Engl J Med. 1999;340(11):847-51.
- 3 Metlaine A, Leger D, Choudat D. Socioeconomic impact of insomnia in working populations. Ind Health. 2005;43(1):11-9.
- 4 Ford DE, Kamerow DB. Epidemiologic study of sleep disturbances and psychiatric disorders. An opportunity for prevention? JAMA. 1989;262(11):1479-84.
- 5 Klink ME, Quan SF, Kaltenborn WT, Lebowitz MD. Risk factors associated with complaints of insomnia in a general adult population. Influence of previous complaints of insomnia. Arch Intern Med. 1992;152(8):1634-7.
- 6 Peker Y, Hedner J, Norum J, Kraiczi H, Carlson J. Increased incidence of cardiovascular disease in middle-aged men with obstructive sleep apnea: a 7-year follow-up. Am J Respir Crit Care Med. 2002;166(2):159-65.
- 7 Wallander MA, Johansson S, Ruigómez A, García Rodriguez LA, Jones R. Morbidity associated with sleep disorders in primary care: a longitudinal cohort study. Prim Care Companion J Clin Psychiatry. 2007;9(5):338-45.
- 8 Drake CL, Rohers T, Richardson G, Walsh JK, Roth T. Shift work sleep disorder: prevalence and consequences beyond that of symptomatic day workers. Sleep. 2004;27(8):1453-62.
- 9 Hetta J, Broman JE, Mallon L. Evaluation of severe insomnia in the general population-implications for the management of insomnia: insomnia, quality of life and health care consumption in Sweden. J Psychopharmacol. 1999;13(4 Suppl. I):S35-6.
- 10 Gonçalves MA, Paiva T, Ramos E, Guilleminault C. Obstructive sleep syndrome, sleepiness, and quality of life. Chest. 2004;125(6):2091-6.
- 11 Lacasse Y, Godbout C, Sériès F. Health-related quality of life in obstructive sleep apnoea. Eur Resp J. 2002;19(3):499-503.
- 12 Téllez López A, Guerrero Sanchez ME, Gutiérrez Torres F, Niño Ramirez MP, Silva Olivares MV. Hábitos y trastornos del dormir en residentes del área metropolitana de Monterrey. Salud Ment. 1995;18(1):14-22.
- 13 Bouscoulet LT, Vázquez-García JC, Muiño A, Márquez M, López MV, de Oca MM, et al. Prevalence of sleep related symptoms in four Latin American cities. J Clin Sleep Med. 2008;4(6):579-85.
- 14 Caraveo Anduaga JJ, Martínez Vélez NA, Rivera B. Un modelo para los estudios epidemiológicos sobre la salud mental y la morbilidad psiquiátrica. Salud Ment. 1998;21(1):48-57.
- 15 Douglass AB, Bornstein R, Nino-Murcia G, Keenan S, Miles L, Zarcone VP Jr, et al. The Sleep Disorders Questionnaire I: Creation and multivariate structure of SDQ. Sleep. 1994;17(2):160-7.
- 16 Ohayon MM. Epidemiology of insomnia: what we know and what we still need to learn. Sleep Med Rev. 2002;6(2):97-111.
- 17 Ohayon MM, Roth T. What are the contributing factors for insomnia in the general population? J Psychsomat Res. 2001;51(6):745-55.
- 18 Ohayon MM, Partinen M. Insomnia and global dissatisfaction in Finland. J Sleep Res. 2002;11(4):339-46.
- 19 Ohayon MM, Lader MH. Use of psychotropic medication in the general population of France, Germany, Italy, and the United Kingdom. J Clin Psychiatry. 2002;63(9):817-25.
- 20 Souza JC, Magna LA, Reimao R. Insomnia and hypnotic use in Campo Grande general population, Brazil. Arq Neuropsiquiatr. 2002;60(3-B):702-7.
- 21 Omvik S, Pallesen S, Bjorvatn B, Sivertsen B, Havik OE, Nordhus IH. Patient characteristics ad predictors of sleep medication use. Int Clin Psychopharmacol. 2010;25(2):91-100.
- 22 Vozoris NT, Leung RS. Sedative medication use: prevalence, risk factors, and associations with body mass index using population-level data. Sleep. 2011;34(7):869-74.
- 23 Goodwin RD, Hasin DS. Sedative use and misuse in the United States. Addiction. 2002;97(5):555-62.
- 24 Kripke DF, Garfinkel L, Wingard DL, Klauber MR, Marler MR. Mortality associated with sleep duration and insomnia. Arch Gen Psychiatry. 2002;59(2):131-6.
- 25 Kripke DF, Langer RD, Kline LE. Hypnotic's association with mortality or cancer: a matched cohort study. BMJ Open. 2012;2(1):e000850. doi: 10.1136/bmjopen-2012-000850.
- 26 Irwin MR, Cole JC, Nicasio PM. Comparative meta-analysis of behavioral interventions for insomnia and their efficacy in middle-aged adults and in older adults 55+ years of age. Health Psychology. 2006;25(1):3-14.
- 27 Morgenthaler T, Kramer M, Alessi C, Friedman L, Boehlecke B, Brown T, et al.; American Academy of Sleep Medicine. Practice parameters for the psychological and behavioral treatment of insomnia: an update. An American Academy of Sleep Medicine Report. Sleep. 2006;29(11):1415-9.
- 28 Ng TP, Seow A, Tan WC. Prevalence of snoring and sleep breathing-related disorders in Chinese, Malay and Indian adults in Singapore. Eur Resp J. 1988;12(1):198-203
- 29 Norton PG, Dunn EV, Haight JS. Snoring in adults: some epidemiologic aspects. Can Med Assoc J. 1983;128(6):674-5.
- 30 Young T, Shahar E, Nieto FJ, Redline S, Newman AB, Gottlieb DJ, et al. Predictors of sleep-disordered breathing in community-dwelling adults: the Sleep Heart Health Study. Arch Intern Med. 2002;162(8):893-900.
- 31 Young T, Peppard PE, Gottlieb DJ. Epidemiology of obstructive sleep apnea: a population health perspective. Am J Respir Crit Care Med. 2002;165(9):1217-39.
- 32 Heinzer R, Vat S, Marques-Vidal P, Marti-Soler H, Andries D, Tobback N, et al. Prevalence of sleep-disordered breathing in the general population: the HypnoLaus study. Lancet Respir Med. 2015;3(4):310-8.
- 33 Tufik S, Santos-Silva R, Taddei JA, Bittencourt LR. Obstructive sleep apnea syndrome in the Sao Paulo Epidemiologic Sleep Study. Sleep Med. 2010:11(5):441-6.
- 34 Berry RB, Budhijara R, Gottlieb DJ, Gozal D, Iber C, Kapur Vet al.; American Academy of Sleep Medicine. Rules for scoring respiratory events in sleep: update of the 2007 AASM Manual for the Scoring of Sleep and Associated Events. Deliberation of the Sleep Apnea Definitions Task Force of the American Academy of Sleep Medicine. J Clin Sleep Med. 2012;8(5):597-619.
- 35 Heinzer R, Marti-Soler H, Haba-Rubio J. Prevalence of sleep apnoea syndrome in the middle to old age general population. Lancet Respir Med. 2016;4(2):e5-6.
- 36 Durán J, Esnaola S, Rubio R, Iztueta A. Obstructive sleep apnea-hypopnea and related clinical features in a population-based simple of subjects aged 30 to 70 yr. Am J Respir Crit Care Med 2001;163:685-9.
- 37 Lajous M, Kurth T, Catzin-Kuhlmann A, Romieu I, López-Ridaura R. Prevalencia del síndrome de piernas inquietas en 69,830 mujeres mexicanas. Rev Invest Clin. 2014;66(4):303-6.
- 38 Ohayon MM, O'Hara R, Vitiello MV. Epidemiology of restless legs syndrome: a synthesis of the literature. Sleep Med Rev. 2012;16(4):283-95.
- 39 Longstreth WT Jr, Koepsell TD, Ton TG, Hendrickson AF, van Belle G. The epidemiology of narcolepsy. Sleep. 2007;30(1):13-26.
- 40 Ohayon MM, Zulley J, Guilleminault C, Smirne S. Prevalence and pathologic associations of sleep paralysis in the general population. Neurology. 1999;52(6):1194-200.
- 41 Sharpless BA, Barber JP. Lifetime prevalence rates of sleep paralysis: a systematic review. Sleep Med Rev. 2011;15(5):311-5.
- 42 Wing YK, Chiu H, Leung T, Ng J. Sleep paralysis in the elderly. J Sleep Res. 1999;8(2):151-5.
- 43 Barquera S, Campos-Nonato I, Hernández Barrera L, Pedroza A, Rivera-Dommarco J. Prevalencia de obesidad en adultos mexicanos, 2000-2012. Salud Pública Méx. 2013;55(Suppl 2):S151-S160.